报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 74.2% | 4373.62% | 6.21% | 27/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 69.86% | 129.4% | 17.33% | 30/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 59.55% | 69.3% | 117.58% | 37/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 27.37% | -54.2% | 1549.93% | 45/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 1.66% | -97.48% | 100.7% | 49/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | -237.63% | -462.55% | -775.62% | 49/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 35.17% | -49.95% | -41.13% | 43/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 59.75% | -14.46% | -9.24% | 35/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 65.83% | -0.38% | 0.44% | 34/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 65.54% | -5.94% | -6.72% | 35/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 70.27% | 35.13% | 0.6% | 30/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 69.85% | 64.79% | 5.7% | 32/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 66.08% | -27.48% | -5.17% | 34/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 69.68% | -23.84% | 34.01% | 34/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 52% | -43.16% | 22.68% | 30/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 42.39% | -54.69% | -53.49% | 42/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 91.13% | -2.23% | -0.4% | 7/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 91.49% | 2% | 0% | 8/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2020-03-31 | 91.49% | 2% | -2.19% | 4/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
2019-12-31 | 93.54% | 3.65% | 0.36% | 4/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
2019-09-30 | 93.21% | 2% | 3.28% | 3/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
2018-12-31 | 90.25% | 100.26% | 100.26% | 7/54 | 71.54% | 我武生物 | 96.46% | 行业排名> |
2017-12-31 | -34434.17% | 2% | 2% | 36/54 | -887.82% | 我武生物 | 96.44% | 行业排名> |